Legislation


A 6605 (see companion bill S 5401) – New York

Status: In Process
Year Introduced: 2021
Link: https://www.nysenate.gov/legislation/bills/2021/A6605

Provides that the price of single source brand-name maintenance medication for which there is no National Average Drug Acquisition Cost pricing shall be the wholesale acquisition cost.


Return to Database Search

© 2018-2019 The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found